Tyto Care raises $50 million as it looks to buy and build new services during COVID-19 demand surge

INSUBCONTINENT EXCLUSIVE:
Tyto Care, the provider of a home health diagnostic device and telemedicine consultation app, said it has raised $50 million in a new round
of funding.The round was led by Insight Partners, Olive Tree Ventures, and Qualcomm Ventures, according to a statement, and brings the
the global response to the COVID-19 pandemic
year, the company inked a deal with Best Buy and works with most of the major telemedicine providers, including American Well, Teladoc and
others.Previous investors Orbimed, Echo Health, Qure, Teuza and others also participated in the new financing, the company said in a
statement.With the financing, Tyto Care is well-positioned to both buy and build new tools based on its existing diagnostics platform, as
well as expand its home health testing kit into new areas.Companies like Scanwell Health are providing at-home diagnostic tests for things
like urinary tract infections, and Tyto Care chief executive Dedi Gilad definitely sees options for new products around different kinds of
technology is being used by every hospital in Israel to provide remote examinations of quarantined and isolated patients infected with
COVID-19
exams can protect health providers from exposure to SARS-Cov-2, the virus that causes COVID-19, and enables uninfected patients to get an
momentum faster than ever before and is playing a leading role in changing how people receive healthcare
Telehealth is heeding the call of the COVID-19 pandemic and we are proud that our unique solution is aiding health systems and consumers